Risks to the 340B Drug Pricing Program.

JAMA

Janssen Scientific Affairs LLC, Titusville, New Jersey.

Published: September 2022

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2022.12753DOI Listing

Publication Analysis

Top Keywords

risks 340b
4
340b drug
4
drug pricing
4
pricing program
4
risks
1
drug
1
pricing
1
program
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!